市場調查報告書
商品編碼
1511239
全球醫療特種袋市場,預測到 2030 年:按產品類型、材料類型、應用、最終用戶和地區Medical Specialty Bags Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球醫療特種袋市場規模將達到 73 億美元,預計到 2030 年將達到 109 億美元,預測期內複合年成長率為 7.0%。
醫用特殊袋是用於醫療環境中收集、儲存和運輸各種醫用液體、檢體和廢棄物的專用容器。這些袋子在患者照護、感染控制和醫療程序中發揮重要作用。常見類型的特殊醫療袋包括用於靜脈輸液和藥物的靜脈輸液袋、用於收集尿液和其他體液的引流袋、用於管理造口手術廢物的造口袋以及用於收集和儲存的捐血袋和樣本袋。
據世界衛生組織(WHO)稱,全世界每年捐獻1.2億單位的捐血,這些血液儲存和輸血活動都需要血袋。
慢性病負擔增加
慢性病通常需要持續的管理和治療,導致居家醫療解決方案的需求增加。特殊醫療袋,例如靜脈輸液袋、造口袋和引流袋,透過促進液體管理、廢物管理和症狀緩解,在居家照護中發揮重要作用。隨著越來越多的患者選擇居家照護來治療慢性病,對特種醫療包的需求也隨之成長。
成本問題和報銷限制
報銷限制和成本問題可能會影響患者獲得基本醫療專業包,特別是患有慢性病或複雜醫療需求的患者。當醫療保健機構因財務限制而無法購買或採購必要的專用包時,患者可能會遇到延遲或次優的護理,或無法獲得所需的醫療干預措施,並可能導致健康結果受損。
提高居家醫療的意識和接受度
遠端醫療和遠端監控技術的引入進一步促進了居家照護。專用醫療包使遠距醫療保健提供者能夠遠端監測患者生命徵象、給藥和收集診斷樣本,以支持遠端醫療舉措的擴展,並改善該地區服務不足的人群獲得醫療保健的機會。
處置挑戰和環境問題
處置挑戰和環境問題可能會限制醫療特種袋市場的研發和創新投資。如果製造商認為市場需求和盈利有限,他們可能不願意引入環保替代品或投資永續產品設計和材料,從而阻礙市場成長和創新。
COVID-19 的影響
由於住院和檢測的增加,對某些類型的特殊袋(例如輸液袋和檢體採集袋)的需求激增,而由於擇期手術的延遲和門診就診的減少,其他領域的需求有所下降。供應鏈和製造流程的中斷也影響了特殊醫療袋的可得性,導致供不應求和物流挑戰。此外,醫療機構對感染控制和安全的擔憂日益增加,導致對一次性醫療產品(包括特種袋)的審查更加嚴格。
預計血袋細分市場將成為預測期內最大的細分市場
由於血袋的供應直接影響捐血計劃和舉措,血袋市場預計將出現良好的成長。捐血中心和流動捐血站應隨時提供血袋,以方便收集和儲存捐血的血液。充足的血袋供應對於維持捐血計畫的有效性和滿足血液製品的需求至關重要,特別是在緊急情況和自然災害期間,從而推動市場成長。
預計聚乙烯領域在預測期內複合年成長率最高
由於其多功能性、靈活性和對各種製造流程的適用性,預計聚乙烯領域在預測期內將出現最高的複合年成長率。聚乙烯可加工成多種形狀,包括低密度聚乙烯(LDPE)、高密度聚苯乙烯(HDPE)和線型低密度聚乙烯(LLDPE),每種形狀均可用於輸液袋、引流袋、檢體採集袋等,具有適合各類醫用袋的特性。
由於人口老化推動了對醫療專用袋的需求,特別是用於管理慢性病和與老齡化相關的健康問題的醫療專用袋,預計亞太地區將在預測期內實現最大的成長,預計將佔據市場佔有率。。用於導尿管、造口護理、傷口處理和靜脈治療的專用袋在老年患者中需求量很大,促進了市場成長。
由於美國食品藥物管理局(FDA) 和衛生署衛生部等機構實施嚴格的監管要求和品質標準,預計北美在預測期內的複合年成長率最高。對於特種醫用袋製造商來說,遵守監管指南對於確保產品安全、有效和市場核准至關重要。
According to Stratistics MRC, the Global Medical Specialty Bags Market is accounted for $7.3 billion in 2024 and is expected to reach $10.9 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Medical specialty bags are specialized containers used for the collection, storage, and transportation of various medical fluids, specimens, and waste in healthcare settings. These bags serve critical roles in patient care, infection control, and medical procedures. Common types of medical specialty bags include intravenous (IV) bags for administering fluids and medications, drainage bags for collecting urine or other bodily fluids, ostomy bags for managing waste from ostomy surgeries, and blood bags for collecting and storing blood donations or samples.
According to the World Health Organisation (WHO), 120 million units of blood are donated annually globally, and these blood storage and transfusion activities require blood bags.
Growing burden of chronic illnesses
Chronic illnesses often require ongoing management and treatment, leading to a rise in demand for home healthcare solutions. Medical specialty bags such as intravenous (IV) infusion bags, ostomy bags, and drainage bags play crucial roles in home-based care by facilitating fluid administration, waste management, and symptom relief. As more patients opt for home-based care to manage their chronic conditions, the demand for medical specialty bags grows correspondingly.
Cost concerns and reimbursement limitations
Reimbursement limitations and cost concerns can affect patient access to essential medical specialty bags, particularly for patients with chronic illnesses or complex medical needs. If healthcare facilities are unable to afford or procure necessary specialty bags due to financial constraints, patients may experience delays in treatment, suboptimal care, or barriers to accessing necessary medical interventions, potentially compromising their health outcomes.
Rising awareness and acceptance of home healthcare
The adoption of telemedicine and remote monitoring technologies has further facilitated the delivery of healthcare services in patients' homes. Medical specialty bags enable remote healthcare providers to monitor patients' vital signs, administer medications, and collect diagnostic samples from a distance, supporting the expansion of telehealth initiatives and improving access to healthcare for remote and underserved populations.
Disposal challenges and environmental concerns
Disposal challenges and environmental concerns may deter investment in research, development, and innovation within the medical specialty bags market. Manufacturers may be hesitant to introduce environmentally-friendly alternatives or invest in sustainable product design and materials if they perceive limited market demand or profitability, hindering market growth and stifling innovation.
Covid-19 Impact
While there was a surge in demand for certain types of specialty bags such as IV infusion bags and specimen collection bags due to increased hospitalizations and testing, other segments experienced declines as elective procedures were postponed and outpatient visits decreased. Disruptions in supply chains and manufacturing processes also affected the availability of medical specialty bags, leading to supply shortages and logistical challenges. Additionally, healthcare facilities faced heightened concerns about infection control and safety, leading to increased scrutiny of disposable medical products, including specialty bags.
The blood bags segment is expected to be the largest during the forecast period
The blood bags segment is estimated to have a lucrative growth, due to the availability of blood bags directly affects blood donation programs and initiatives. Blood bags need to be readily accessible to blood donation centers and mobile blood drives to facilitate the collection and storage of donated blood. Adequate supplies of blood bags are essential for maintaining blood donation programs' effectiveness and meeting the demand for blood products, particularly during emergencies or natural disasters driving the market growth.
The polyethylene segment is expected to have the highest CAGR during the forecast period
The polyethylene segment is anticipated to witness the highest CAGR growth during the forecast period, due to its versatility, flexibility, and compatibility with various manufacturing processes. It can be processed into different forms, including low-density polyethylene (LDPE), high-density polyethylene (HDPE), and linear low-density polyethylene (LLDPE), each offering specific properties suitable for different types of medical bags, such as IV infusion bags, drainage bags, and specimen collection bags.
Asia Pacific is projected to hold the largest market share during the forecast period owing to \ the region's aging population is driving demand for medical specialty bags, particularly those used in the management of chronic conditions and age-related health issues. Specialty bags for urinary catheters, ostomy care, wound management, and intravenous therapy are in high demand among elderly patients, contributing to market growth.
North America is projected to have the highest CAGR over the forecast period, as North America is subject to stringent regulatory requirements and quality standards enforced by agencies such as the Food and Drug Administration (FDA) in the United States and Health Canada. Compliance with regulatory guidelines is essential for manufacturers of medical specialty bags to ensure product safety, efficacy, and market approval.
Key players in the market
Some of the key players in the Medical Specialty Bags Market include Ambu AS, B Braun Medical, Baxter International Inc., C.R. Bard Inc, Cardinal Health Inc., Coloplast A/S, Convatec Inc., DuPont, Fresenius Medical Care AG & Co., Hollister Incorporated, Kawasumi Laboratories Inc., Macopharma, Medisave, Nolato AB, Pall Corporation, Persico S.p.a., Terumo Corporation, UNIFLEX HEALTHCARE, Versapak International Ltd and Westfield Medical Ltd.
In April 2024, Ambu announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) of its new generation duodenoscopy solution, Ambu(R) aScope(TM) Duodeno 2 and Ambu(R) aBox(TM) 2, for use in ERCP1 procedures.
In April 2024, Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S. Five new launches reinforce Baxter's focus on differentiated products and enhance the company's Pharmaceuticals portfolio in critical therapeutic areas
In April 2024, Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy. Offering the Novum IQ LVP in the U.S. demonstrates Baxter's commitment to continued innovation in advancing infusion therapy.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.